Login / Signup

Romiplostim for chemotherapy-induced thrombocytopenia: Efficacy and safety of extended use.

Cy R WilkinsJocelyn OrtizLeah J GilbertShen YinJodi V MonesRekha ParameswaranSimon ManthaGerald A Soff
Published in: Research and practice in thrombosis and haemostasis (2022)
Long-term use of romiplostim for treatment of CIT was effective and safe, with no evidence of resistance or increased risk of thrombosis.
Keyphrases
  • chemotherapy induced
  • pulmonary embolism